This session reviews the most common areas of noncompliance identified during sterile compounding inspections, including issues related to SOPs, training, supervision, facility maintenance, and environmental monitoring. It highlights how gaps in documentation, inconsistent adherence to procedures, and inadequate oversight can contribute to compliance risks. By understanding these frequent findings, pharmacies can better identify vulnerabilities and take proactive steps to strengthen their compounding practices and inspection readiness.